1. Evaluation of antitumor activity of survivin short interfering RNA delivered by lipid nanoparticles in colon cancer in vitro and in vivo
    Tianyou Wang et al, 2017, Oncology Letters CrossRef
  2. Nontyphoidal Salmonella : a potential anticancer agent
    K. Jazeela et al, 2020, Journal of Applied Microbiology CrossRef
  3. Enhanced bacterial cancer therapy delivering therapeutic RNA interference of c-Myc
    Jason S. Williams et al, 2024, Cell & Bioscience CrossRef
  4. Sequence‐dependent combination therapy with doxorubicin and a survivin‐specific small interfering RNA nanodrug demonstrates efficacy in models of adenocarcinoma
    Subrata K. Ghosh et al, 2014, International Journal of Cancer CrossRef
  5. Optimizing the restored chemotactic behavior of anticancer agent Salmonella enterica serovar Typhimurium VNP20009
    Katherine M. Broadway et al, 2017, Journal of Biotechnology CrossRef
  6. Combining DNA Vaccine and AIDA-1 in AttenuatedSalmonellaActivates Tumor-Specific CD4+ and CD8+ T-cell Responses
    Yu Mei et al, 2017, Cancer Immunology Research CrossRef
  7. Synthetic biology expands chemical control of microorganisms
    Tyler J Ford et al, 2015, Current Opinion in Chemical Biology CrossRef
  8. Inhibition of murine breast cancer growth and metastasis by survivin-targeted siRNA using disulfide cross-linked linear PEI
    Shan Liu et al, 2016, European Journal of Pharmaceutical Sciences CrossRef
  9. Enhancement of Gastric Ulcer Healing and Angiogenesis by Hepatocyte Growth Factor Gene Mediated by AttenuatedSalmonellain Rats
    Xiaoqin Ha et al, 2017, Journal of Korean Medical Science CrossRef
  10. Salmonella Typhimurium as an Anticancer Therapy: Recent Advances and Perspectives
    Katherine M. Broadway et al, 2019, Current Clinical Microbiology Reports CrossRef
  11. Targeted Cancer Therapy Using EngineeredSalmonella typhimurium
    Jin Hai Zheng et al, 2016, Chonnam Medical Journal CrossRef
  12. Tumour-targeting bacteria engineered to fight cancer
    Shibin Zhou et al, 2018, Nature Reviews Cancer CrossRef
  13. Survivin-targeting Artificial MicroRNAs Mediated by Adenovirus Suppress Tumor Activity in Cancer Cells and Xenograft Models
    Yudan Chi et al, 2014, Molecular Therapy - Nucleic Acids CrossRef
  14. Bactofection, Bacterial-Mediated Vaccination, and Cancer Therapy: Current Applications and Future Perspectives
    Francisco Israel Renteria-Flores et al, 2024, Vaccines CrossRef
  15. Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy
    Kajal H. Gupta et al, 2021, Vaccines CrossRef